User menu

High seroprevalence of hepatitis B virus and hepatitis C virus among human immunodeficiency virus carriers in blood donors of Burkina Faso: a need for their screening before HARRT therapy

Bibliographic reference Kirakoya, Fati ; Sanou, Mahamoudou ; Samadoulougou, Sékou Ouindpanga ; Bakiono, Fidèle ; Kiénou, K. ; et. al. High seroprevalence of hepatitis B virus and hepatitis C virus among human immunodeficiency virus carriers in blood donors of Burkina Faso: a need for their screening before HARRT therapy. In: Journal of Viral Hepatitis, Vol. 21, p. e52–e53 (2014)
Permanent URL http://hdl.handle.net/2078.1/187612
  1. WHO The world health report http://www.who.int/whr/2002/annex/en/
  2. Matthews Gail V, Bartholomeusz Angeline, Locarnini Stephen, Ayres Anna, Sasaduesz Joe, Seaberg Eric, Cooper David A, Lewin Sharon, Dore Gregory J, Thio Chloe L, Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy : , 10.1097/01.aids.0000218550.85081.59
  3. Hoffmann Christopher J, Thio Chloe L, Clinical implications of HIV and hepatitis B co-infection in Asia and Africa, 10.1016/s1473-3099(07)70135-4
  4. WHO Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: towards universal access. Recommendations for a public health approach (2006 revision) http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf